Balancing weight and muscle loss in GLP1 receptor agonist therapy
When undergoing treatment with GLP-1 analogues like semaglutide, Wegovy, Ozempic, Rybelsus, Retatrutide, and Tirzepatide for obesity and type 2 diabetes management, regularly measuring and monitoring your blood biomarkers becomes vital
However, it needs: A lifetime of weekly shots to sustain its effects $1,000-$1,400 per month The weight comes back after you stop taking it Up to 18-22% reduction of body weight compared to 30-35% for gastric bypass surgery When considering lifelong treatment and people with a BMI of at least 35, bariatric surgery allows one to lose more weight AND no injections are required anymore
How quickly will I notice results
Depending on the intended site of action and nature of the gene-editing, the outcome of such treatment could differ drastically from the transient effects on both IgG and albumin achieved by first-generation FcRn antagonists
The medication should always be used as part of a comprehensive approach including dietary modification and increased physical activity